Medical Technology

@xconomy.com 3 years ago

Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally

@xconomy.com 3 years ago

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

@xconomy.com 4 years ago

Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill

@xconomy.com 4 years ago

FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes

@xconomy.com 4 years ago

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

@xconomy.com 4 years ago

Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 4 years ago

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

@xconomy.com 4 years ago

WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More

@xconomy.com 4 years ago

Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September

@xconomy.com 4 years ago

FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms

@xconomy.com 5 years ago

Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo

@xconomy.com 5 years ago

Ohio Insurer Turns to Propeller Health for Digital Approach to COPD

@xconomy.com 5 years ago

Digital Tools, Online Community & More: Patient Partnership Award Finalists

@xconomy.com 5 years ago

Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More

@xconomy.com 5 years ago

Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision

@xconomy.com 5 years ago

Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets

@xconomy.com 5 years ago

Fixing the Clinical Trial Bottleneck by Making Patients a Priority